Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKingswood H. Regulatory News (KWG)

  • There is currently no data for KWG

Deferred consideration payment for Admiral

4 Nov 2022 07:00

RNS Number : 2902F
Kingswood Holdings Limited
03 November 2022
 

3 November 2022

Kingswood Holdings Limited

(" Kingswood" or the "Group")

 

Deferred consideration payment for Admiral Wealth Management

Settlement of second deferred consideration payment regarding the Admiral Wealth Management business and assets acquired in August 2021

Kingswood Holdings Limited (AIM: KWG), the international fully integrated wealth and investment management group, is pleased to announce that it has made the second year 1 deferred consideration payment in the amount of £0.5m relating to the acquisition of Admiral Wealth Management Limited, as announced on 18 August 2021.

 

A portion of the cash proceeds from Kingswood's new funding facility, announced on 17 October 2022, have been used to make this deferred consideration payment.

 

ENDS 

 

For further details, please contact:

Kingswood Holdings Limited

+44 (0)20 7293 0730

David Lawrence

www.kingswood-group.com

finnCap Ltd (Nomad & Broker)

+44 (0)20 7220 0500

Simon Hicks / Abigail Kelly

GreenTarget (for Kingswood media)

Jamie Brownlee / Alice Gasson / Ellie Basle 

+44 (0)20 7324 5498

Jamie.Brownlee@greentarget.co.uk

 

About Kingswood

Kingswood Holdings Limited (trading as Kingswood) is an AIM-listed (AIM: KWG) international fully integrated wealth management group with circa £9.5bn billion of Assets under Advice and Management. It services circa 19,000 clients from a growing network of offices in the UK including Abingdon, Beverley, Conisbrough, Darlington, Derby, Eastleigh, Grimsby, Harrogate, Hull, Lincoln, London, Maidstone, Newcastle, Penn, Sheffield (2), Worcester and York with overseas offices in Johannesburg, South Africa and Atlanta, New York and San Diego in US.

Kingswood offers a range of trusted investment solutions to its clients, which range from private individuals to some of the UK's largest universities and institutions, including investment advice and management, personal and company pensions and wealth planning. Kingswood is focused on becoming a leading player in the wealth and investment management market through targeted acquisitions in the UK and US, creating a global business through strategic partnerships.

Registered office address: Mont Crevelt House, Bulwer Avenue, St. Sampson, Guernsey, GY2 4LH

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBJBLTMTTMBTT
Date   Source Headline
17th Apr 20257:00 amRNSCancellation - Kingswood Holdings Limited
16th Apr 20257:15 amRNSDay 21 Acceptance Level Update
25th Mar 20257:05 amRNSPublication of the Offer Document
25th Mar 20257:00 amRNSOffer for Kingswood Holdings Limited
24th Mar 20253:30 pmRNSForm 8.3 - Kingswood Holdings Limited
21st Mar 202511:32 amRNSForm 8 (OPD) for HSQ Investment Limited
20th Mar 20259:25 amRNSForm 8.5 (EPT/NON-RI)
20th Mar 20259:23 amRNSForm 8.5 (EPT/NON-RI)
18th Mar 20255:09 pmRNSFORM 8 (OPD) - Kingswood Holdings Limited
18th Mar 20257:00 amRNSUnconditional Cash Offer by HSQ Investment Limited
14th Mar 20254:24 pmRNSAdditional Debt Facility
14th Mar 20251:15 pmRNSForm 8 (DD) - Kingswood Holdings Limited
14th Mar 202512:34 pmRNSDirector/PDMR Shareholding
14th Mar 20257:01 amRNSBoard Change
14th Mar 20257:00 amRNSDirector/PDMR Shareholdings
13th Mar 20256:33 pmRNSForm 8 (DD) - Kingswood Holdings Limited
13th Mar 20256:33 pmRNS17.1 Announcement (75% threshold)
12th Mar 20257:55 amRNSFinancial Position Update & Possible Offer
10th Jan 20257:00 amRNSPermanent CEO Appointment
3rd Dec 20242:34 pmRNSResults of Annual General Meeting
18th Nov 20247:55 amRNSNotice of AGM
31st Oct 20247:00 amRNSAdditional Debt Facility
30th Sep 202412:07 pmRNSFurther re Kingswood 2024 Half year Report
30th Sep 20247:00 amRNS2024 Half-year Report
15th Aug 20247:00 amRNSKingswood additional debt facility
22nd Jul 20247:00 amRNSRelated Party Transaction
5th Jul 20247:00 amRNSAppointment of Interim CEO
28th Jun 20247:00 amRNSFinal results
31st May 20247:00 amRNSConversion of Convertible Preference Shares
7th May 20247:00 amRNSKingswood Additional Debt Facility
16th Feb 20247:00 amRNSKingswood secures new debt facility
6th Feb 20249:00 amRNSKingswood's Irish subsidiary acquires BasePlan Ltd
29th Dec 20237:00 amRNSConversion of Convertible Preference Shares
1st Dec 20237:00 amRNSBoard changes
30th Nov 202312:30 pmRNSResult of AGM
15th Nov 20239:45 amRNSNotice of AGM
9th Nov 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20238:40 amRNSDirector/PDMR Shareholding
12th Oct 20233:15 pmRNSDirector/PDMR Shareholding
6th Oct 20235:00 pmRNSDeferred consideration payment
29th Sep 20237:00 amRNSKingswood 2023 Half-year Report
21st Aug 20235:00 pmRNSLong Term Incentive Plan Award
24th May 20237:00 amRNSKingswood 2022 audited financial results
15th Mar 20237:00 amRNSTrading Statement
6th Mar 20232:05 pmRNSSecond Price Monitoring Extn
6th Mar 20232:00 pmRNSPrice Monitoring Extension
6th Mar 202311:05 amRNSSecond Price Monitoring Extn
6th Mar 202311:00 amRNSPrice Monitoring Extension
6th Mar 20237:00 amRNSStatement re Press Comment
3rd Mar 20237:00 amRNSKingswood acquires Moloney Investments Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.